Premium
Detection of anti‐acetylcholine receptor antibody by an ELISA using human receptor from a rhabdomyosarcoma cell line
Author(s) -
Martino G.,
Twaddle G.,
Brambilla E.,
Grimaldi L. M. E.
Publication year - 1994
Publication title -
acta neurologica scandinavica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.967
H-Index - 95
eISSN - 1600-0404
pISSN - 0001-6314
DOI - 10.1111/j.1600-0404.1994.tb01626.x
Subject(s) - myasthenia gravis , antibody , acetylcholine receptor , microbiology and biotechnology , antigen , monoclonal antibody , alkaline phosphatase , chemistry , receptor , immunology , biology , enzyme , biochemistry
A simple and reliable enzyme‐linked immunosorbent assay (ELISA) has been developed for the measurement of anti‐acetylcholine receptor (AChR) antibodies. The test utilizes a membrane‐bound AChR obtained from a human rabdomyosarcoma cell line (TE671) as antigen and employs an affinity‐purified rabbit anti‐human immunoglobulin G alkaline phosphatase‐conjugated antibody as labelled antibody. To assess the sensitivity and the specificity of our assay we tested serum samples from 13 anti‐AChR antibody‐positive myasthenia gravis (MG) patients known to contain between 2 and 120 nmol/l of anti‐AChR antibody, three anti‐AChR antibody‐negative MG patients, and 70 control subjects including patients with other neurological and autoimmune diseases. A panel of six different anti‐AChR monoclonal antibodies and membranes from a AChR‐negative rat adrenal pheochromocytoma cell line (PC 12) were also used in competitive studies. The test showed to be specific and able to detect as low as 2.0 nmol/l of anti‐AChR antibodies. Moreover, we found a good correspondence between anti‐AChR antibody levels measured in the serum samples tested by our assay and levels measured by the routinely adopted radioimmuno assay (RIA) using human‐AChR (r = 0.96). Cross‐reaction phenomena were observed only using serum samples containing high‐titer anti‐DNA antibodies. The proposed ELISA, circumventing the limitation of the commonly used RIA (radioactivity and amputated legs as source of human antigen), can be considered as an useful screening test for the diagnosis of myasthenia gravis.